These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 18537540)

  • 21. Beta-amyloid oligomers affect the structure and function of the postsynaptic region: role of the Wnt signaling pathway.
    Dinamarca MC; Colombres M; Cerpa W; Bonansco C; Inestrosa NC
    Neurodegener Dis; 2008; 5(3-4):149-52. PubMed ID: 18322375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-n oligomers as therapeutic targets of Alzheimer's disease.
    Ono K; Yamada M
    J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C; Agostinho P; Moreira PI; Cardoso SM; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):383-403. PubMed ID: 16101556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.
    Kawarabayashi T; Shoji M; Younkin LH; Wen-Lang L; Dickson DW; Murakami T; Matsubara E; Abe K; Ashe KH; Younkin SG
    J Neurosci; 2004 Apr; 24(15):3801-9. PubMed ID: 15084661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A beta oligomers - a decade of discovery.
    Walsh DM; Selkoe DJ
    J Neurochem; 2007 Jun; 101(5):1172-84. PubMed ID: 17286590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
    Klein WL
    J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain.
    Takahashi RH; Almeida CG; Kearney PF; Yu F; Lin MT; Milner TA; Gouras GK
    J Neurosci; 2004 Apr; 24(14):3592-9. PubMed ID: 15071107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease as oligomeropathy.
    Ono K
    Neurochem Int; 2018 Oct; 119():57-70. PubMed ID: 28821400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
    J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
    J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J; Lefort R; Shelanski ML
    Neuroscience; 2013 Oct; 251():51-65. PubMed ID: 22687952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.
    Brito-Moreira J; Lourenco MV; Oliveira MM; Ribeiro FC; Ledo JH; Diniz LP; Vital JFS; Magdesian MH; Melo HM; Barros-Aragão F; de Souza JM; Alves-Leon SV; Gomes FCA; Clarke JR; Figueiredo CP; De Felice FG; Ferreira ST
    J Biol Chem; 2017 May; 292(18):7327-7337. PubMed ID: 28283575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuronal pentraxin 1 contributes to the neuronal damage evoked by amyloid-beta and is overexpressed in dystrophic neurites in Alzheimer's brain.
    Abad MA; Enguita M; DeGregorio-Rocasolano N; Ferrer I; Trullas R
    J Neurosci; 2006 Dec; 26(49):12735-47. PubMed ID: 17151277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
    Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
    PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.